Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy:: Results of a prospective trial and preliminary guidelines for standardized contours

被引:380
|
作者
Viswanathan, Akila N.
Dimopoulos, Johannes
Kirisits, Christian
Berger, Daniel
Potter, Richard
机构
[1] Med Univ Vienna, Dept Radiotherapy & Radiobiol, A-1090 Vienna, Austria
[2] Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA
关键词
cervical cancer; brachytherapy; computed tomography; magnetic resonance imaging;
D O I
10.1016/j.ijrobp.2006.12.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To compare the contours and dose-volume histograms (DVH) of the tumor and organs at risk (OAR) with computed tomography (CT) vs. magnetic resonance imaging (MRI) in cervical cancer brachytherapy. Methods and Materials: Ten patients underwent both MRI and CT after applicator insertion. The dose received by at least 90% of the volume (D-90), the minimal target dose (D-100), the volume treated to the prescription dose or greater for tumor for the high-risk (HR) and intermediate-risk (IR) clinical target volume (CTV) and the dose to 0.1 cm(3), 1 cm(3), and 2 cm(3) for the OARs were evaluated. A standardized approach to contouring on CT (CTStd) was developed, implemented (HR- and IR-CTVCTStd), and compared with the MRI contours. Results: Tumor height, thickness, and total volume measurements, as determined by either CT or CTStd were not significantly different compared with the MRI volumes. In contrast, the width measurements differed in HR-CTVCTStd (p = 0.05) and IR-CTVCTStd(p = 0.01). For the HR-CTVCTStd, this resulted in statistically significant differences in the volume treated to the prescription dose or greater (MRI, 96% vs. CTStd, 86 %, p = 0.01), D-100 (MRI, 5.4 vs. CTStd, 3.4, p < 0.01), and D-90 (MRI, 8.7 vs. CTStd, 6.7, p < 0.01). Correspondingly, the IR-CTV DVH values on MRI vs. CTStd, differed in the D-100 (MRI, 3.0 vs. CTStd, 2.2, p = 0.01) and D-90 (MRI, 5.6 vs. CTStd, 4.6, p = 0.02). The MRI and CT DVH values of the dose to 0.1 cm(3), 1 cm(3), and 2 cm(3) for the OARs were similar. Conclusion: Computed tomography-based or MRI-based scans at brachytherapy are adequate for OAR DVH analysis. However, CT tumor contours can significantly overestimate the tumor width, resulting in significant differences in the D90, D100, and volume treated to the prescription dose or greater for the HR-CTV compared with that using MRI. MRI remains the standard for CTV definition. (C) 2007 Elsevier Inc.
引用
收藏
页码:491 / 498
页数:8
相关论文
共 50 条
  • [1] Comment on "Computed tomography versus magnetic resonance IMAGING-BASED contouring in cervical cancer brachtherapy:: Results of a prospective trial and preliminary guidelines for standardized contours" by Viswanathan et al. -: Reply
    Viswanathan, Akila N.
    Kirisits, Christian
    Dimopoulos, Johannes
    Berger, Daniel
    Potter, Richard
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : 963 - 964
  • [2] Comparison of computed tomography with magnetic resonance imaging for imaging-based clinical target volume contours in cervical cancer brachytherapy
    Zolciak-Siwinska, Agnieszka
    Kowalczyk, Adam
    Sikorska, Katarzyna
    Bijok, Michal
    Michalski, Wojciech
    Gruszczynska, Ewelina
    BRACHYTHERAPY, 2018, 17 (04) : 667 - 672
  • [3] Comparison of Computed Tomography- and Magnetic Resonance Imaging-based Clinical Target Volume Contours at Brachytherapy for Cervical Cancer
    Swanick, Cameron W.
    Castle, Katherine O.
    Vedam, Sastry
    Munsell, Mark F.
    Turner, Lehendrick M.
    Rauch, Gaiane M.
    Jhingran, Anuja
    Eifel, Patricia J.
    Klopp, Ann H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (04): : 793 - 800
  • [4] Comparison of computed tomography- and magnetic resonance imaging-based target delineation for cervical cancer brachytherapy
    Wang, Fang
    Bu, Luyi
    Wu, Qun
    Jiang, Xue
    Wu, Lingyun
    Li, Yu
    Xi, Bin
    Lu, Zhongjie
    Yan, Senxiang
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2020, 12 (04) : 367 - 374
  • [5] Comparison of Computed Tomography and Magnetic Resonance Imaging in Cervical Cancer Brachytherapy Target and Normal Tissue Contouring
    Eskander, Ramez N.
    Scanderbeg, Daniel
    Saenz, Cheryl C.
    Brown, Michelle
    Yashar, Catherine
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (01) : 47 - 53
  • [6] Deformable Image Registration Improves Contouring Accuracy in Magnetic Resonance Imaging-Based Cervical Brachytherapy
    Chapman, C. H.
    Polan, D.
    Jolly, S.
    Prisciandaro, J. I.
    Brock, K. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E669 - E669
  • [7] Single Magnetic Resonance Imaging vs Magnetic Resonance Imaging/Computed Tomography Planning in Cervical Cancer Brachytherapy
    Beriwal, S.
    Kim, H.
    Coon, D.
    Mogus, R.
    Heron, D. E.
    Li, X.
    Huq, M. S.
    CLINICAL ONCOLOGY, 2009, 21 (06) : 483 - 487
  • [8] Comparison of initial computed tomography-based target delineation and subsequent magnetic resonance imaging-based target delineation for cervical cancer brachytherapy
    Corriher, Taylor J.
    Dutta, Sunil W.
    Alonso, Clayton E.
    Libby, Bruce
    Romano, Kara D.
    Showalter, Timothy N.
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2020, 12 (03) : 279 - 282
  • [9] Dosimetric Evaluation of Magnetic Resonance Imaging-based Intracavitary Brachytherapy for Cervical Cancer
    Kim, Y. J.
    Kim, J. Y.
    Kim, T. H.
    Lim, Y. K.
    Yoon, M. G.
    Joo, J. N.
    Park, S. Y.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2014, 13 (03) : 243 - 251
  • [10] Comparison of computed tomography and magnetic resonance imaging in cervical cancer brachytherapy: A systematic review
    Wang, Fang
    Tang, Qiuying
    Lv, Guoxiao
    Zhao, Feng
    Jiang, Xue
    Zhu, Xinli
    Li, Xinke
    Yan, Senxiang
    BRACHYTHERAPY, 2017, 16 (02) : 353 - 365